Current review on squamous intraepithelial lesions of the larynx

Histopathology

Volumn 54, Issue 6, 2009, Pages 639-656

  Gale, Nina ^a   Michaels, Leslie ^b   Luzar, Bostjan ^a   Poljak, Mario ^a   Zidar, Nina ^a   Fischinger, Janez ^c   Cardesa, Antonio ^d  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Aetiology; Follow up; Histopathological classifications; Larynx; Molecular biology; Squamous intraepithelial lesions; Treatment

Indexed keywords

ALPHA INTERFERON; ALPHA TOCOPHEROL; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 4; ISOTRETINOIN; TELOMERASE REVERSE TRANSCRIPTASE;

BASAL PARABASAL HYPERPLASIA; BCL 1 GENE; BIOPSY; CANCER RADIOTHERAPY; CARBON DIOXIDE LASER; CARCINOGENESIS; CARCINOMA IN SITU; CELL HYPERPLASIA; CLINICAL FEATURE; COMPARATIVE STUDY; DISEASE CLASSIFICATION; EMS 1 GENE; EXCISIONAL BIOPSY; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GENE; GENETIC ANALYSIS; GENETIC MARKER; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INT 2 GENE; LARYNX; LARYNX CARCINOMA; MICROSURGERY; MOLECULAR BIOLOGY; NONHUMAN; PRAD1 GENE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL HYPERPLASIA; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LARYNX; MALE; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRUS INFECTIONS; SMOKING;

HUMAN PAPILLOMAVIRUS;

EID: 65349114737     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03111.x     Document Type: Review

References (189)

1. Ha PK, Califano J. The molecular biology of laryngeal cancer. Otolaryngol. Clin. North Am. 2002 3 993 1012. (Pubitemid 35397195)
2. Gale N, Pilch BZ, Sidransky D, Westra WH, Califano J. Epithelial precursor lesions. In Barnes L, Eveson JW, Reichart P, Sidransky D eds. World Health Organization classification of tumour. Pathology and genetics of head and neck tumours. Lyon : IARC, 2005 140 143.
3. Gale N, Zidar N. Benign and potentially malignant lesions of the squamous epithelium and squamous cell carcinoma. In Cardesa A, Slootweg P eds. Pathology of the head and neck. Berlin : Springer, 2006 1 38.
4. Kambič V, Gale N. Significance of keratosis and dyskeratosis for classifying hyperplastic aberrations of laryngeal mucosa. Am. J. Otolaryngol. 1986 7 323 333. (Pubitemid 17174846)
5. Crissman JD, Visscher DW, Sakr W. Premalignant lesions of the upper aerodigestive tract: pathologic classification. J. Cell. Biochem. Suppl. 1993 17F 49 56. (Pubitemid 23252921)
6. Putney FJ, O'Keefe JJ. The clinical significance of keratosis of the larynx as a premalignant lesion. Ann. Otol. Rhinol. Laryngol. 1953 62 348 357.
7. McGavran MH, Bauer WC, Ogura JH. Isolated laryngeal keratosis. Its relation to carcinoma of the larynx based on a clinicopathologic study of 87 consecutive cases with long-term follow-up. Laryngoscope 1960 70 932 951.
8. Kambič V. Difficulties in management of vocal cord precancerous lesions. J. Laryngol. Otol. 1978 92 305 315.
9. Crissman JD. Laryngeal keratosis and subsequent carcinoma. Head Neck Surg. 1979 1 386 391.
10. Henry RC. The transformation of laryngeal leucoplakia to cancer. J. Laryngol. Otol. 1979 93 447 459.
11. Hellquist H, Lundgren J, Olofsson J. Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords-a follow-up study. Clin. Otolaryngol. 1982 7 11 27. (Pubitemid 12171431)
12. Gillis TM, Incze J, Strong MS, Vaughan CW, Simpson GT. Natural history and management of keratosis, atypia, carcinoma in situ, and microinvasive cancer of the larynx. Am. J. Surg. 1983 146 512 516.
13. Grundmann E. Classification and clinical consequences of precancerous lesions in the digestive and respiratory tracts. Acta Pathol. Jpn. 1983 33 195 217. (Pubitemid 14141032)
14. Goodman ML. Keratosis (leukoplakia) of the larynx. Otolaryngol. Clin. North Am. 1984 17 179 183. (Pubitemid 14143466)
15. Crissman JD, Fu YS. Intraepithelial neoplasia of the larynx. Arch. Otolaryngol. Head Neck Surg. 1986 112 522 528.
16. Velasco JRR, Nieto CS, de Bustos CP, Marcos CA. Premalignant lesions of the larynx: pathological prognostic factors. J. Otolaryngol. 1987 16 367 370. (Pubitemid 18031758)
17. Olde Kalter P, Lubsen H, Delemarre JFM, Snow GB. Squamous cell hyperplasia of the larynx. A clinical follow-up study. J. Laryngol. Otol. 1987 101 579 588. (Pubitemid 17082067)
18. Crissman JD, Zarbo RJ. Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract. Am. J. Surg. Pathol. 1989 13 (Suppl. I 5 16. (Pubitemid 19142060)
19. Sllamniku B, Bauer W, Painter C, Sessions D. The transformation of laryngeal keratosis into invasive carcinoma. Am. J. Otolaryngol. 1989 10 42 54. (Pubitemid 19073049)
20. Bouquot JE, Kurland LT, Weiland LH. Laryngeal keratosis and carcinoma in Rochester, MN, population, 1935-1984. Cancer Detect. Prev. 1991 15 83 91.
21. Kambič V, Gale N, Ferluga D. Laryngeal hyperplastic lesions, follow-up study and application of lectins and anticytokeratins for their evaluation. Path. Res. Pract. 1992 188 1067 1077. (Pubitemid 23073430)
22. Blackwell KE, Fu YS, Calcaterra TC. Laryngeal dysplasia. A clinicopathologic study. Cancer 1995 75 457 463.
23. Kambič V, Gale N. Epithelial hyperplastic lesions of the larynx. Amsterdam : Elsevier, 1995 1 265.
24. Hellquist H, Cardesa A, Gale N, Kambič V, Michaels L. Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the Working group on Epithelial Hyperplastic Laryngeal Lesions of the European Society of Pathology. Histopathology 1999 34 226 233. (Pubitemid 129755367)
25. Gale N, Kambič V, Michaels L et al. The Ljubljana classification: a practical strategy for the diagnosis of laryngeal precancerous lesions. Adv. Anat. Pathol. 2000 7 240 251.
26. Gallo A, de Vincentiis M, Della Rocca C et al. Evolution of precancerous laryngeal lesions: a clinicopathologic study with long-term follow-up on 259 patients. Head Neck 2001 23 42 47. (Pubitemid 32040955)
27. Ricci G, Molini E, Faralli M, Simoncelli C. Retrospective study on precancerous laryngeal lesions: long-term follow-up. Acta Otorhinolaryngol. Ital. 2003 23 362 367.
28. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res. 1992 52 5997 6000.
29. Shin DM, Kim J, Ro JY et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 1994 54 321 326. (Pubitemid 24053159)
30. Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS, Gluckman JL. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 1993 119 1118 1122. (Pubitemid 23303092)
31. Voravud N, Shin DM, Ro JY, Lee JS, Hong WK, Hittelman WN. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res. 1993 53 2874 2883. (Pubitemid 23180530)
32. Jares P, Fernandez PL, Campo E et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994 54 4813 4817. (Pubitemid 24276517)
33. Califano J, van der Riet P, Westra W et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996 56 2488 2492. (Pubitemid 26170679)
34. Field JK. Genomic instability in squamous cell carcinoma of the head and neck. Anticancer Res. 1996 16 2421 2431. (Pubitemid 26325425)
35. Gallo O, Santucci M, Franchi A. Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions. J. Natl Cancer Inst. 1997 89 1161 1163. (Pubitemid 27337931)
36. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin. Cancer Res. 2000 6 347 352. (Pubitemid 30111449)
37. Veltman JA, Bot FJ, Huynen FC, Ramaekers FC, Manni JJ, Hopman AH. Chromosome instability as an indicator of malignant progression in laryngeal mucosa. J. Clin. Oncol. 2000 18 1644 1651. (Pubitemid 30220542)
38. Franchi A, Gallo O, Sardi I, Santucci M. Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis. J. Clin. Pathol. 2001 54 201 204. (Pubitemid 32205040)
39. Nadal A, Cardesa A. Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch. 2003 442 1 7. (Pubitemid 36216353)
40. Sanz-Ortega J, Valor C, Saez MC et al. 3p21, 5q21, 9p21 and 17p13 allelic deletions accumulate in the dysplastic spectrum of laryngeal carcinogenesis and precede malignant transformation. Histol. Histopathol. 2003 18 1053 1057. (Pubitemid 37265008)
41. Chatrath P, Scott IS, Morris LS et al. Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. Br. J. Cancer 2003 89 1048 1054. (Pubitemid 37239210)
42. Yoo WJ, Cho SH, Lee YS et al. Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx. J. Korean Med. Sci. 2004 19 345 351. (Pubitemid 38859822)
43. Kleist B, Poetsch M. Divergent patterns of allelic alterations in premalignant laryngeal lesions indicate differences in the impact of morphological grading characteristics. Oncology 2004 67 420 427.
44. Jeannon JP, Soames JV, Aston V, Stafford FW, Wilson JA. Molecular markers in dysplasia of the larynx: expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk. Clin. Otolaryngol. Allied Sci. 2004 29 698 704. (Pubitemid 39557005)
45. Chi FL, Yuan YS, Wang SY, Wang ZM. Study on ceramide expression and DNA content in patients with healthy mucosa, leukoplakia, and carcinoma of the larynx. Arch. Otolaryngol. Head Neck Surg. 2004 130 307 310. (Pubitemid 38314229)
46. Yuge T, Nibu K, Kondo K, Shibahara J, Tayama N, Sugasawa M. Loss of FHIT expression in squamous cell carcinoma and premalignant lesions of the larynx. Ann. Otol. Rhinol. Laryngol. 2005 114 127 131. (Pubitemid 40250248)
47. Sadri M, McMahon J, Parker A. Laryngeal dysplasia: aetiology and molecular biology. J. Laryngol. Otol. 2006 120 170 177. (Pubitemid 44127312)
48. Brieger J, Kastner J, Gosepath J, Mann WJ. Evaluation of microsatellite amplifications at chromosomal locus 3q26 as surrogate marker for premalignant changes in mucosa surrounding head and neck squamous cell carcinoma. Cancer Genet. Cytogenet. 2006 167 26 31.
49. Guo T, Sun JW, Lv QP, Li XG. Allelic imbalance on chromosomes 3p, 9p and 17p in malignant progression of laryngeal mucosa. J. Laryngol. Otol. 2008 122 72 77.
50. Fraczek M, Wozniak Z, Ramsey D, Krecicki T. Epression patterns of cyclin E, cyclin A and CDC25 phosphatases in laryngeal carcinogenesis. Eur. Arch. Otorhinolaryngol. 2007 264 923 928. (Pubitemid 47025054)
51. Saglam O, Shah V, Worsham MJ. Molecular differentiation of early and late stage laryngeal squamous cell carcinoma: an exploratory analysis. Diagn. Mol. Pathol. 2007 16 218 221. (Pubitemid 350196979)
52. Bouquot JE, Gnepp DR. Laryngeal precancer: a review of the literature, commentary, and comparison with oral leukoplakia. Head Neck 1991 13 488 497.
53. Kambič V. Epithelial hyperplastic lesions - a challenging topic in laryngology. Acta Otolaryngol. (Stockh). 1997 527 (Suppl. 7 11. (Pubitemid 27241736)
54. Luna MA, Pineda-Daboin K. Upper aerodigestive tract. In Henson DF, Albores-Savedra J eds. Pathology of incipient neoplasi, 3rd edn. Oxford : New York, 2001 57 85.
55. Wenig BM. Squamous cell carcinoma of the upper aerodigestive tract: precursors and problematic variants. Mod. Pathol. 2002 15 229 254. (Pubitemid 34246620)
56. Kambič V, Radšel Z, Gale N. Alterations in the laryngeal mucosa after exposure to asbestos. Br. J. Ind. Med. 1989 46 717 723. (Pubitemid 19256304)
57. Muller KM, Krohn RB. Smoking habits and their relationship to precancerous lesions of the larynx. J. Cancer Res. Clin. Oncol. 1980 96 211 217. (Pubitemid 10174139)
58. Grasl MCH, Neuwirth-Riedl K, Vutuc C, Horak F, Vorbeck F, Banyai M. Risk of vocal cord dysplasia in relation to smoking, alcohol intake and occupation. Eur. J. Epidemiol. 1990 6 45 48. (Pubitemid 20132547)
59. Neuwirth-Riedl K, Grasel M, Horak F, Vorbeck F. Wie verhalten sich Stimmbanddysplasien bei unterschiedlichen Rauchgewohnheiten? Laryngo-Rhino-Otologie 1990 69 512 514. (Pubitemid 20352191)
60. Maier H, Dietz A, Gewelke U, Heller WD, Weidauer H. Tobacco and alcohol in the risk of head and neck cancer. Clin. Invest. 1992 70 320 327.
61. DeStefani E, Oreggia F, Rivero S, Fierro L. Hand-rolled cigarette smoking and risk of cancer of the mouth, pharrynx and larynx. Cancer 1992 70 679 682.
62. Tavani A, Negri E, Franceschi S, Barbone F, La Vecchia C. Attributable risk for laryngeal cancer in northern Italy. Cancer Epidemiol. Biomarkers Prev. 1994 3 121 125. (Pubitemid 24170053)
63. Cuchi A, Bombi JA, Avellaneda R, Cardesa A, Traserra J. Precancerous lesions of the larynx: clinical and pathologic correlations and prognostic aspects. Head Neck 1994 16 545 549. (Pubitemid 24326616)
64. Blackwell KE, Calcaterra TC, Fu YS. Laryngeal dysplasia: epidemiology and treatment outcome. Ann. Otol. Rhinol. Laryngol. 1995 104 596 602.
65. Fiorella R, DiNicola V, Resta L. Epidemiological and clinical relief on hyperplastic lesions of the larynx. Acta Otolaryngol. (Stockh). 1997 527 (Suppl. 77 81. (Pubitemid 27241752)
66. Maier H, Tisch M. Epidemiology of laryngeal cancer: results of the Heidelberg case-control study. Acta Otolaryngol. (Stockh). 1997 527 (Suppl. 160 164. (Pubitemid 27241774)
67. Bosatra A, Bussani R, Silvestri F. From epithelial dysplasia to squamous carcinoma in the head and neck region: an epidemiological assessment. Acta Otolaryngol. 1997 527 (Suppl. 47 48. (Pubitemid 27241744)
68. Gallus S, Bosetti C, Franceschi S, Levi F, Negri E, La Vecchia C. Laryngeal cancer in women: tobacco, alcohol, nutritional, and hormonal factors. Cancer Epidemiol. Biomarkers Prev. 2003 12 514 517. (Pubitemid 36713645)
69. Vaezi MF, Qadeer MA, Lopez R, Colabianchi N. Laryngeal cancer and gastroesophageal reflux disease: a case-control study. Am. J. Med. 2006 119 768 776. (Pubitemid 44291628)
70. Koskinen WJ, Brøndbo K, Mellin Dahlstrand H et al. Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J. Cancer Res. Clin. Oncol. 2007 133 673 678. (Pubitemid 47077059)
71. Wynder EL, Stellman SD. Comparative epidemiology of tobacco-related cancers. Cancer Res. 1977 37 4608 4622.
72. Olson NR. Effects of stomach acid on the larynx. Proc. Am. Laryngol. Assoc. 1983 104 108 112.
73. Morrison MD. Is chronic gastroesophageal reflux a causative factor in glottic carcinoma? Otolaryngol. Head Neck Surg. 1988 99 370 373. (Pubitemid 18252364)
74. Ward PH, Hanson DG. Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope 1988 98 1195 1199. (Pubitemid 18275832)
75. Freije JE, Beatty TW, Campbell BH, Woodson BT, Schultz CJ, Toohill RJ. Carcinoma of the larynx in patients with gastroesophageal reflux. Am. J. Otolaryngol. 1996 17 386 390. (Pubitemid 26393766)
76. Copper MP, Smit CF, Stanojcic LD, Devriese PP, Schouwenburg PF, Mathus-Vliegen LM. High incidence of laryngopharyngeal reflux in patients with head and neck cancer. Laryngoscope 2000 110 1007 1011. (Pubitemid 30368649)
77. Lewin JS, Gillenwater AM, Garrett JD et al. Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx. Cancer 2003 97 1010 1014. (Pubitemid 36173152)
78. El-Serag HB, Hepworth EJ, Lee P, Sonnenberg A. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am. J. Gastroenterol. 2001 96 2013 2018. (Pubitemid 32660891)
79. Qadeer MA, Colabianchi N, Vaezi MF. Is GERD a risk factor for laryngeal cancer? Laryngoscope 2005 115 486 491. (Pubitemid 40327998)
80. Cianci R, Galli J, Agostino S et al. Gastric surgery as a long-term risk factor for malignant lesions of the larynx. Arch. Surg. 2003 138 751 754. (Pubitemid 36858154)
81. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999 189 12 19. (Pubitemid 29406813)
82. Syrjänen KJ, Syrjänen SM. Histological evidence for the presence of condylomatous epithelial lesions in association with laryngeal squamous cell carcinoma. ORL J. Otorhinolaryngol. Relat. Spec. 1981 43 181 194.
83. Syrjanen K, Syrjanen S, Pyrhonen S. Human papilloma virus (HPV) antigens in lesions of laryngeal squamous cell carcinomas. ORL J. Otorhinolaryngol. Relat. Spec. 1982 44 323 334.
84. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J. Clin. Virol. 2005 32 (Suppl. 1 S59 S66. (Pubitemid 40332590)
85. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin. Otolaryngol. 2006 31 259 266. (Pubitemid 44141088)
86. Smith EM, Summersgill KF, Allen J et al. Human papillomavirus and risk of laryngeal cancer. Ann. Otol. Rhinol. Laryngol. 2000 109 1069 1076.
87. de Oliveira DE, Bacchi MM, Macarenco RS, Tagliarini JV, Cordeiro RC, Bacchi CE. Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am. J. Clin. Pathol. 2006 126 284 293. (Pubitemid 44162576)
88. Szentirmay Z, Pólus K, Tamás L et al. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations. Cancer Metastasis Rev. 2005 24 19 34. (Pubitemid 40576061)
89. Torrente MC, Ampuero S, Abud M, Ojeda JM. Molecular detection and typing of human papillomavirus in laryngeal carcinoma specimens. Acta Otolaryngol. 2005 125 888 893. (Pubitemid 41224111)
90. Torrente MC, Ojeda JM. Exploring the relation between human papilloma virus and larynx cancer. Acta Otolaryngol. 2007 127 900 906. (Pubitemid 47345803)
91. Venuti A, Manni V, Morello R, De Marco F, Marzetti F, Marcante ML. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J. Med. Virol. 2000 60 396 402. (Pubitemid 30127310)
92. Jacob SE, Sreevidya S, Chacko E, Pillai MR. Cellular manifestations of human papillomavirus infection in laryngeal tissues. J. Surg. Oncol. 2002 79 142 150.
93. Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2008 14 366 369.
94. Poljak M, Gale N, Kambič V. Human papillomaviruses: a study of their prevalence in the epithelial hyperplastic lesions of the larynx. Acta Otolaryngol. 1997 527 (Suppl. 66 99.
95. Gorgoulis V, Rassidakis G, Karameris A, Giatromanolaki A, Barbatis C, Kittas C. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings. Virchows Arch. 1994 425 481 489.
96. Gallo O, Bianchi S, Giannini A, Boccuzzi S, Calzolari A, Fini-Storchi O. Lack of detection of human papillomavirus (HPV) in transformed laryngeal keratoses by in situ hybridization (ISH) technique. Acta Otolaryngol. 1994 114 213 217. (Pubitemid 24098460)
97. Fouret P, Martin F, Flahault A, Saint-Guily JL. Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn. Mol. Pathol. 1995 4 122 127.
98. Lindeberg H, Krogdahl A. Laryngeal dysplasia and the human papillomavirus. Clin. Otolaryngol. Allied Sci. 1997 22 382 386. (Pubitemid 28346981)
99. Azzimonti B, Hertel L, Aluffi P et al. Demonstration of multiple HPV types in laryngeal premalignant lesions using polymerase chain reaction and immunohistochemistry. J. Med. Virol. 1999 59 110 116. (Pubitemid 29362174)
100. Gorgoulis VG, Zacharatos P, Kotsinas A et al. Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum. Pathol. 1999 30 274 283. (Pubitemid 29125146)
101. Brito H, Vassallo J, Altemani A. Detection of human papillomavirus in laryngeal squamous dysplasia and carcinoma. An in situ hybridization and signal amplification study. Acta Otolaryngol. 2000 120 540 544. (Pubitemid 34098305)
102. Rihkanen H, Peltomaa J, Syrjanen S. Prevalence of human papillomavirus (HPV) DNA in vocal cords without laryngeal papillomas. Acta Otolaryngol. 1994 114 348 351. (Pubitemid 24198908)
103. Nunez DA, Astley SM, Lewis FA, Wells M. Human papilloma viruses: a study of their prevalence in the normal larynx. J. Laryngol. Otol. 1994 108 319 320. (Pubitemid 24125768)
104. Hobbs CG, Birchall MA. Human papillomavirus infection in the etiology of laryngeal carcinoma. Curr. Opin. Otolaryngol. Head Neck Surg. 2004 12 88 92. (Pubitemid 38420195)
105. Kambič V, Radšel Z, Preželj J, Žargi M. The role of testosterone in laryngeal carcinogenesis. Am. J. Otolaryngol. 1984 5 344 349. (Pubitemid 14023787)
106. Parnes SM. Asbestos and cancer of the larynx: is there a relationship? Laryngoscope 1990 100 254 261. (Pubitemid 20135035)
107. Muscat JE, Wynder EL. Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer. Cancer 1992 69 2244 2251.
108. Lentsch EJ, Myers JN. New trends in the etiology, diagnosis, and management of laryngeal dysplasia. Curr. Opin. Otolaryngol. Head Neck Surg. 2001 9 74 78. (Pubitemid 32231085)
109. Kleinsasser O. Tumors of the larynx and hypopharynx. Stuttgart : Georg Time, 1988 61 123.
110. Gale N, Zidar N, Poljak M, Luzar B. Epithelial hyperplastic laryngeal lesions. Histopathology 2002 41 (Suppl. 2 477 480.
111. Jackson C. Cancer of the larynx: is it preceded by a recognizable precancerous condition? Ann. Surg. 1923 77 1 14.
112. Michaels L, Hellquist HB. Ear, nose and throat histopathology, 2nd edn. London : Springer, 2001 378 387.
113. McLaren KM, Burnett RA, Goodland JR et al. The Scottish Pathology Consistency Group. Consistency of histopathological reporting of laryngeal dysplasia. Histopathology 2000 37 460 463.
114. Crissman JD. Laryngeal keratosis preceding laryngeal carcinoma. A report of four cases. Arch. Otolaryngol. 1982 108 445 448. (Pubitemid 12085099)
115. Friedmann I, Ferlito A. Precursors of squamous cell carcinoma. In Ferlito A ed. Neoplasms of the laryn. Edinburgh : Churchill Livingstone, 1993 97 111.
116. Resta L, Colucci GA, Troia M, Russo S, Vacca E, Pesce Delfino V. Laryngeal intraepithelial neoplasia (LIN). An analytical morphometric approach. Path. Res. Pract. 1992 188 517 523.
117. Dreyer T, Glanz H. Laryngeal epithelial dysplasia vs. laryngeal intraepithelial neoplasia Pathologe. Pathologe 2004 25 9 13. (Pubitemid 38235203)
118. Kambič V, Lenart I. Notre classification des hyperplasies de l'épithélium du larynx au point de vue pronostic. JFORL 1971 20 1145 1150.
119. Bosman FT. Dysplasia classification: pathology in disgrace? J. Pathol. 2001 194 143 144. (Pubitemid 32519961)
120. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006 42 987 993. (Pubitemid 44573884)
121. Serio G, Gale N, Pennella A et al. The Ljubljana classification of epithelial hyperplastic laryngeal lesions: a morphometric evaluation of nuclear pleomorphism. Pathologica 2002 94 290 298. (Pubitemid 36157407)
122. Nagy P. The Ljubljana classification of epithelial hyperplastic laryngeal lesions. Orv. Hetil. 2003 144 2415 2417.
123. Sengiz S, Pabuççuòlu U, Sariòlu S. Immunohistological comparison of the World Health Organization (WHO) and Ljubljana classifications on the grading of preneoplastic lesions of the larynx. Pathol. Res. Pract. 2004 200 181 188. (Pubitemid 38950428)
124. Crissman JD, Sakr WA. Squamous intraepithelial neoplasia of the upper aerodigestive tract. In Gnepp DR ed. Diagnostic surgical pathology of the head and nec. Philadelphia : W.B. Saunders, 2000 1 17.
125. Sakr WA, Gale N, Gnepp DR. Squamous intraepithelial neoplasia of the upper aerodigestive tract. In Gnepp DR ed. Diagnostic surgical pathology of the head and neck. 2nd edn. Philadelphia : W.B. Saunders, 2008 in press. (Pubitemid 19027543)
126. 2 laser. Acta Otorhinolaryngol. Ital. 2001 21 32 43.
127. Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol. Carcinog. 1993 7 139 146. (Pubitemid 23161701)
128. van der Riet P, Nawroz H, Hruban RH et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 1994 54 1156 1158. (Pubitemid 24108049)
129. Sardi I, Franchi A, De Campora L, Passali GC, Gallo O. Microsatellite instability as an indicator of malignant progression in laryngeal premalignancy. Head Neck 2006 28 730 739. (Pubitemid 44116898)
130. Kamb A, Shattuck-Eidens D, Eeles R et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet. 1994 8 23 26. (Pubitemid 24274056)
131. Merlo A, Herman JG, Mao L et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1995 1 686 692.
132. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993 366 704 707. (Pubitemid 24036021)
133. Kim MM, Califano JA. Molecular pathology of head-and-neck cancer. Int. J. Cancer 2004 112 545 553. (Pubitemid 39425933)
134. Hasina R, Lingen MW. Head and neck cancer: the pursuit of molecular diagnostic markers. Semin. Oncol. 2004 31 718 725. (Pubitemid 39602677)
135. Balz V, Scheckenbach K, Götte K, Bockmühl U, Petersen I, Bier H. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res. 2003 63 1188 1191. (Pubitemid 36348693)
136. Boyle JO, Hakim J, Koch W et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993 53 4477 4480. (Pubitemid 23304366)
137. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003 63 1727 1730. (Pubitemid 36460827)
138. Poeta ML, Manola J, Goldwasser MA et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 2007 357 2552 2561. (Pubitemid 350294222)
139. Callender T, el-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994 74 152 158. (Pubitemid 24187623)
140. Namazie A, Alavi S, Olopade OI et al. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 2002 112 472 481. (Pubitemid 34225863)
141. Pomerantz RG, Grandis JR. The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. Semin. Oncol. 2004 31 734 443. (Pubitemid 39602679)
142. Irish JC, Bernstein A. Oncogenes in head and neck cancer. Laryngoscope 1993 103 42 52. (Pubitemid 23028804)
143. Shin DM, Ro JY, Hong WK, Hittelman WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 1994 54 3153 3159. (Pubitemid 24208920)
144. Gale N, Zidar N, Kambic V, Poljak M, Cör A. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx. Acta Otolaryngol. 1997 527 (Suppl. 105 110. (Pubitemid 27241759)
145. Sorrells DL Jr., Ghali GE, De Benedetti A, Nathan CA, Li BD. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers. J. Oral Maxillofac. Surg. 1999 57 294 299. (Pubitemid 29109360)
146. Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope 2002 112 2129 2140. (Pubitemid 35417033)
147. Nathan CO, Franklin S, Abreo FW, Nassar R, De Benedetti A, Glass J. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. J. Clin. Oncol. 1999 17 2909 2914. (Pubitemid 29415252)
148. Haydon MS, Googe JD, Sorrells DS, Ghali GE, Li BD. Progression of eIF4e gene amplification and overexpression in benign and malignant tumors of the head and neck. Cancer 2000 88 2803 2810. (Pubitemid 30417942)
149. Franklin S, Pho T, Abreo FW et al. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers. Arch. Otolaryngol. Head Neck Surg. 1999 125 177 182. (Pubitemid 29085266)
150. Liang Z, Lei T, LuYing Z, YuPing G. The expression of proto-oncogene eIF4E in laryngeal squamous cell carcinoma. Laryngoscope 2003 113 1238 1243. (Pubitemid 36835573)
151. Nathan CO, Leskov IL, Lin M et al. COX-2 expression in dysplasia of the head and neck: correlation with elF4E. Cancer 2001 92 1888 1895. (Pubitemid 32952508)
152. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953 6 963 968.
153. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res. 1996 56 2484 2487. (Pubitemid 26170678)
154. Almadori G, Bussu F, Cadoni G et al. Multistep laryngeal carcinogenesis helps our understanding of the field cancerisation phenomenon: a review. Eur. J. Cancer 2004 40 2383 2388. (Pubitemid 39424950)
155. Meyerson M, Counter CM, Eaton EN et al. Telomerase activity in human cancer. Curr. Opin. Oncol. 1996 8 66 71. (Pubitemid 26093745)
156. Shay JW, Wright WE. Telomerase activity in human cancer. Curr. Opin. Oncol. 1996 8 66 71. (Pubitemid 26093745)
157. Luzar B, Poljak M, Marin IJ, Fischinger J, Gale N. Quantitative measurement of telomerase catalytic subunit (hTERT) mRNA in laryngeal squamous cell carcinomas. Anticancer Res. 2001 21 4011 4015. (Pubitemid 34229278)
158. De Kok JB, Schalken JA, Aalders TW, Reurs TJM, Willems HL, Swinkels DW. Quantitative measurement of telomerase reverse trascriptase (hTERT) mRNA in urothelial cell carcinomas. Int. J. Cancer 2000 87 217 220. (Pubitemid 30434348)
159. Kyo S, Kanaya T, Takakura M, Tanaka M, Inoue M. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int. J. Cancer 1999 80 60 63. (Pubitemid 28559777)
160. Luzar B, Poljak M, Marin IJ, Gale N. Telomerase reactivation is an early event in laryngeal carcinogenesis. Mod. Pathol. 2003 16 841 848. (Pubitemid 37152012)
161. Dolcetti R, Doglioni C, Maestro R et al. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int. J. Cancer 1992 52 178 182.
162. Barbatis C, Loukas L, Grigoriou M et al. p53 overexpression in laryngeal squamous cell carcinoma and dysplasia. Clin. Mol. Pathol. 1995 48 M194 M197.
163. Nadal A, Campo E, Pinto J et al. p53 expression in normal, dysplastic,
164. Poljak M, Gale N, Kambic V, Ferluga D, Fischinger J. Overexpression of p53 protein in benign and malignant laryngeal epithelial lesions. Anticancer Res. 1996 16 1947 1951. (Pubitemid 26270708)
165. Uhlman DL, Adams G, Knapp D, Aeppli DM, Niehans G. Immunohistochemical staining for markers of future neoplastic progression in the larynx. Cancer Res. 1996 56 2199 2205. (Pubitemid 26119925)
166. Hirai T, Hayashi K, Takumida M, Ueda T, Hirakawa K, Yajin K. Reduced expression of p27 is correlated with progression in precancerous lesions of the larynx. Auris Nasus Larynx 2003 30 163 168. (Pubitemid 36566599)
167. Ioachim E, Peschos D, Goussia A et al. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. J. Exp. Clin. Cancer Res. 2004 23 277 283. (Pubitemid 38943560)
168. Munck-Wikland E, Edström S, Jungmark E, Kuylenstierna R, Lindholm J, Auer G. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int. J. Cancer 1994 56 95 99. (Pubitemid 24044799)
169. Wayne S, Robinson RA. Upper aerodigestive tract squamous dysplasia: correlation with p16, p53, pRb, and Ki-67 expression. Arch. Pathol. Lab. Med. 2006 130 1309 1314. (Pubitemid 44373066)
170. Zidar N, Gale N, Cör A, Kambic V. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx. J. Laryngol. Otol. 1996 110 440 445. (Pubitemid 126732701)
171. Pignataro L, Capaccio P, Pruneri G et al. The predictive value of p53, MDM-2, cyclin D1 and Ki67 in the progression from low-grade dysplasia towards carcinoma of the larynx. J. Laryngol. Otol. 1998 112 455 459. (Pubitemid 28271840)
172. Leopardi G, Serafini G, Simoncelli C, Ludovini V, Pistola L, Altissimi G. Ki67 and p53 in laryngeal epithelial lesions: correlations with risk factors. Acta Otorhinolaryngol. Ital. 2001 21 243 247.
173. Peschos D, Stefanou D, Vougiouklakis T, Assimakopoulos DA, Agnantis NJ. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis. J. Exp. Clin. Cancer Res. 2005 24 431 437. (Pubitemid 41416128)
174. Bračko M. Evaluation of DNA content in epithelial hyperplastic lesions of the larynx. Acta Otolaryngol. 1997 527 (Suppl. 62 65. (Pubitemid 27241748)
175. Munck-Wikland E, Kuylenstierna R, Lindholm J, Auer G. Image cytometry DNA analysis of dysplastic squamous epithelial lesions in the larynx. Anticancer Res. 1991 11 597 600.
176. Crissman JD, Zarbo RJ. Quantitation of DNA ploidy in squamous intraepithelial neoplasia of the laryngeal glottis. Arch. Otolaryngol. Head Neck Surg. 1991 117 182 188.
177. Choi G, Chung K. Polysomies of chromosomes 7 and 17 in head and neck squamous cell carcinomas. Arch. Otolaryngol. Head Neck Surg. 1996 122 1062 1067. (Pubitemid 26337142)
178. Gale N, Kambic V, Poljak M, Cör A, Velkavrh D, Mlacak B. Chromosomes 7,17 polysomies and overexpression of epidermal growth factor receptor and p53 protein in epithelial hyperplastic laryngeal lesions. Oncology 2000 58 117 125. (Pubitemid 30113862)
179. Kim MM, Clinger JD, Masayesva BG et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin. Cancer Res. 2004 10 8512 8515. (Pubitemid 40053417)
180. Zeitels SM. Laser versus cold instruments for microlaryngoscopic surgery. Laryngoscope 1996 106 545 552. (Pubitemid 26137831)
181. 2 laser in laryngeal microsurgery. Int. Surg. 1987 72 175 178.
182. Thumfart WF, Eckel HE. Endolaryngeal laser surgery in the treatment of laryngeal cancers. The current Cologne concept. HNO 1990 38 174 178. (Pubitemid 20204936)
183. Hirano M, Sato K. Laser surgery for epithelial hyperplasia of the vocal fold. Ann. Otol. Rhinol. Laryngol. 1993 102 85 91. (Pubitemid 23057595)
184. Sadri M, McMahon J, Parker A. Management of laryngeal dysplasia: a review. Eur. Arch. Otorhinolaryngol. 2006 263 843 852. (Pubitemid 44127312)
185. Schweinfurth JM, Fedok F. Avoiding pitfalls and unfavorable outcomes in scar revision. Facial Plast. Surg. 2001 17 273 278. (Pubitemid 33136221)
186. Lubsen H, Olde Kalter PH. Premalignant laryngeal lesions. Acta Otorhinolaryngol. Belg. 1992 46 117 126.
187. Fein DA, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Carcinoma in situ of the glottic larynx: the role of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1993 27 379 384. (Pubitemid 23304465)
188. Johnson FL. Management of advanced premalignant laryngeal lesions. Curr. Opin. Otolaryngol. Head Neck Surg. 2003 11 462 466. (Pubitemid 37468161)
189. Plch J, Pár I, Navrátilová I, Bláhová M, Zavadil M. Long term follow-up study of laryngeal precancer. Auris Nasus Larynx 1998 25 407 412. (Pubitemid 28530036)